HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

MINUTES OF PROCEEDINGS

Meeting No. 36

Tuesday, March 27, 2012

The Standing Committee on Health met at 8:50 a.m. this day, in Room 306, La Promenade Building, the Chair, Joy Smith, presiding.

Members of the Committee present: Kelly Block, Libby Davies, Parm Gill, Wladyslaw Lizon, Dany Morin, Anne Minh-Thu Quach, Djaouida Sellah and Joy Smith.

Acting Members present: Ted Hsu for Hon. Hedy Fry, Kellie Leitch for Mark Strahl and Rick Norlock for Colin Carrie.

In attendance: Library of Parliament: Raphaelle Deraspe, Analyst ; Sonya Norris, Analyst.

Witnesses: Canadian Association for Pharmacy Distribution Management: David Johnston, President and Chief Executive Officer; Allan Reynolds, Vice-President, Industry and Member Relations. Canadian Generic Pharmaceutical Association: Jim Keon, President; Jeremy Desai, President and Chief Operating Officer, Apotex Inc.; Michel Robidoux, President, Sandoz Canada. Canada's Research-Based Pharmaceutical Companies (Rx & D): Russell Williams, President; Mark Ferdinand, Senior Director, Health and Economic Policy. HealthPRO Procurement Services Inc.: Kathleen Boyle, Vice-President, Services; Michael Blanchard, Clinical Director, Pharmacy Services.

Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Tuesday, March 13, 2012, the Committee commenced its study of the role of government and industry in determining drug supply in Canada.

On motion of Kelly Block, it was agreed, — That in relation to the study of the role of government and industry in determining drug supply in Canada, the proposed budget in the amount of $18,450 be adopted.

Jim Keon, Russell Williams, David Johnston and Kathleen Boyle made statements and, with Michel Robidoux, Mark Ferdinand, Michael Blanchard and Jeremy Desai, answered questions.

At 10:46 a.m., the Committee adjourned to the call of the Chair.

Mariane Beaudin
Clerk of the Committee

2012/03/30 10:35 a.m.